<DOC>
<DOCNO>
EP-0011301
</DOCNO>
<TEXT>
<DATE>
19800528
</DATE>
<IPC-CLASSIFICATIONS>
A61K-51/00 A61K-51/04 A61K-51/02 
</IPC-CLASSIFICATIONS>
<TITLE>
composition and method for labelling red blood cells with radioactive technetium; process and kit for preparing the composition.
</TITLE>
<APPLICANT>
nihon mediphysics co ltdjp<sep>nihon-medi physics co., ltd. <sep>nihon medi-physics co., ltd.no 4-2-1, takatsukasa takarazuka-shihyogo-kenjp   <sep>
</APPLICANT>
<INVENTOR>
hazue masaakijp<sep>kato makotojp<sep>hazue, masaaki<sep>kato, makoto<sep>hazue, masaaki3-2-1, mukomotomachi amagasakihyogojp<sep>kato, makoto1-4-7, warizukadouri fukiai-kukobe hyogojp<sep>
</INVENTOR>
<ABSTRACT>
a non-radioactive composition for intracorporeal label­ ing of red blood cells with radioactive technetium, which  comprises (a) at least one of pyridoxal and its salts, (b) at least  one stannous salt and (c) at least one α-amino acid as the  essential components, of which the administeration through  a vein in a living body can assure an efficient intracorporeal  labeling of red blood cells in the living body with radioactive  technetium which is subsequently administered through the  vein.  
</ABSTRACT>
</TEXT>
</DOC>
